PharmaCielo Ltd.
PCLOF
$0.02
$0.00-3.31%
OTC PK
| 09/30/2025 | 06/30/2025 | 09/30/2024 | 09/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.01M | -940.30K | -1.94M | -1.94M | -1.80M |
| Total Depreciation and Amortization | 61.80K | 14.50K | -20.60K | 183.10K | 69.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 861.00K | 926.90K | 1.56M | 1.36M | 644.90K |
| Change in Net Operating Assets | -2.48M | 1.53M | -5.30K | -5.30K | 768.90K |
| Cash from Operations | -2.56M | 1.53M | -405.10K | -405.10K | -311.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 5.38M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | -- | 30.50K |
| Cash from Investing | 5.38M | -- | 0.00 | 0.00 | 30.50K |
| Total Debt Issued | 25.00K | 125.00K | 0.00 | 607.00K | 315.00K |
| Total Debt Repaid | -3.67M | -2.29M | -68.20K | -68.20K | -61.40K |
| Issuance of Common Stock | -- | -- | 607.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 237.00K |
| Cash from Financing | -2.65M | -1.56M | 395.10K | 395.10K | 363.90K |
| Foreign Exchange rate Adjustments | 10.10K | -1.50K | -500.00 | -600.00 | 2.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 181.50K | -34.40K | -10.50K | -10.50K | 85.30K |